Liver Disease Clinical Trials

Showing 641-660 of 1,279 trials

HEAL STUDY (Hepatic Encephalopathy and Albumin Study)

NCT03585257

Patients with continued cognitive impairment after episodes of HE have few options beyond lactulose and rifaximin in the US. Therefore using IV albumin in a randomized, double-blind, placebo-controlled trial, which could beneficially impact inflammation, could be an additional approach to improve cognition. This 6 week trial will study changes in cognition, HRQOL and inflammation in patients with covert HE after prior overt HE using multiple IV albumin infusions vs. placebo.

CirrhosisHepatic EncephalopathyMinimal Hepatic Encephalopathy+1 more

Hunter Holmes Mcguire Veteran Affairs Medical Center48 participantsStarted Jun 2018

Richmond, Virginia, United States

UNKNOWN

Intraoperative Normal Saline Administration and Acute Kidney Injury in Patients Undergoing Liver Transplantation

NCT05386953

The investigators attempted to investigate the association of the type of crystalloid administered during liver transplantation with postoperative clinical outcomes. The investigators hypothesized that the greater amount of normal saline or half-saline administered during liver transplantation might be associated with the increased risk of acute kidney injury compared to the balanced crystalloids.

End Stage Liver DIseaseLiver Transplant; ComplicationsLiver Cirrhosis

Seoul National University Hospital1,440 participantsStarted Apr 2022

Seoul, South Korea

HEAL STUDY (Hepatic Encephalopathy and Albumin Study)

Intraoperative Normal Saline Administration and Acute Kidney Injury in Patients Undergoing Liver Transplantation

Related Searches

Impact of Acute Kidney Injury on Sarcopenia and Frailty in Patients With Liver Cirrhosis

Hepatic and Cardiac Metabolic Flexibility in Obese With NAFLD.

In Vivo Determination of Cytochrome P450 Activities in Patients With Liver Cirrhosis

Assessment Of Lipid Profile In Cirrhotic Patients

Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease

Ketogenic Diet in Non-alcoholic Fatty Liver Disease

The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology

Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study

Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis

Liver Fat and Iron Quantification MRI

Orphenadrine Versus Baclofen in Treatment of Muscle Cramps in Cirrhotic Patients

COVID-19 Vaccines in Patients With Chronic Liver Disease

19Gauge Fine Needle Biopsy (FNB) Versus 22Gauge FNB for Endoscopic Ultrasound Guided Liver Biopsy (EUS-LB)

A Model Based on Computed Tomography Imaging Parameters to Predict Poor Survival in Patients With Liver Cirrhosis

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance

A Study to Assess the Impact of Implementing Modified Early Warning Score in Terms of Competency and Self-efficacy of Nurses at ILBS, Delhi

Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease)

Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C Trial